scispace - formally typeset
A

Anders Sönnerborg

Researcher at Karolinska Institutet

Publications -  432
Citations -  21283

Anders Sönnerborg is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Viral load & Virus. The author has an hindex of 66, co-authored 407 publications receiving 19240 citations. Previous affiliations of Anders Sönnerborg include University of Missouri & University College London.

Papers
More filters
Journal ArticleDOI

Use of InfCare HIV to identify and characterize suboptimally treated HIV patients at a Danish HIV clinic: A cross-sectional cohort study

TL;DR: This study investigated the usefulness of InfCare HIV for identifying and characterizing suboptimally treated HIV-infected patients at a Danish HIV clinic and found that it was successfully used to identify patients with suboptimal treatment.
Journal ArticleDOI

Symptomatic Patients without Epidemiological Indicators of HIV Have a High Risk of Missed Diagnosis: A Multi-Centre Cross Sectional Study.

TL;DR: Individuals without epidemiological indicators of HIV are more likely to have a history of missed presentations, to neglect symptoms and to take an initiative to test for HIV themselves, compared to patients infected heterosexually.
Journal Article

Differences in PCR reactivity between HIV proviruses from individuals in Ethiopia and Sweden.

TL;DR: Results suggest that the burden of HIV-1 DNA in peripheral mononuclear blood cells increases with advancing disease, and PCR using primer pairs designed to detect HIV- 1 infection in Europe and North America is not always suitable for the detection of HIV/1 infection in Ethiopia.
Journal ArticleDOI

Suppressive antiretroviral therapy associates with effective treatment of high-grade cervical intraepithelial neoplasia.

TL;DR: Assessment of if women living with HIV (WLWH) have poorer outcome after treatment of cervical intraepithelial neoplasia grade 2, grade 3, adenocarcinoma in situ or cervical cancer (CIN2+) than HIV-negative women (HNW) and to identify predictors of CIN2+ treatment failure and recurrence in WLWH found suppression of CD4+ cell count associated with treatment failure.